Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,229,000 | 9,809,000 | 6,485,000 | 6,315,000 | 12,851,000 |
| Marketable Securities | 3,666,000 | 2,457,000 | 2,267,000 | 2,004,000 | 1,756,000 |
| Receivables | 4,514,000 | 5,075,000 | 5,752,000 | 6,163,000 | 5,854,000 |
| Inventories | 1,587,000 | 1,900,000 | 1,862,000 | 1,880,000 | 1,955,000 |
| Income taxes - deferred | N/A | 762,000 | 835,000 | 830,000 | 828,000 |
| TOTAL | $19,588,000 | $21,425,000 | $18,353,000 | $19,267,000 | $24,762,000 |
| Non-Current Assets | |||||
| PPE Net | 2,865,000 | 2,714,000 | 2,599,000 | 2,431,000 | 2,276,000 |
| Investments And Advances | 20,485,000 | 19,345,000 | 15,864,000 | 13,003,000 | 11,601,000 |
| Intangibles | 10,143,000 | 10,558,000 | 10,885,000 | 11,095,000 | 11,419,000 |
| Other Non-Current Assets | 3,896,000 | 2,567,000 | 2,279,000 | 1,969,000 | 1,658,000 |
| TOTAL | $37,389,000 | $35,184,000 | $31,627,000 | $28,498,000 | $26,954,000 |
| Total Assets | $56,977,000 | $56,609,000 | $49,980,000 | $47,765,000 | $51,716,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 700,000 | 700,000 | 1,745,000 | 982,000 |
| Accounts payable and accrued liabilities | 1,206,000 | 1,052,000 | 1,122,000 | 945,000 | 1,178,000 |
| Accrued Expenses | 5,021,000 | 5,482,000 | 5,447,000 | 4,766,000 | 4,118,000 |
| TOTAL | $9,218,000 | $11,073,000 | $10,444,000 | $10,910,000 | $9,890,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,643,000 | 26,555,000 | 21,894,000 | 21,451,000 | 21,468,000 |
| Deferred Revenues | N/A | 361,000 | 345,000 | 529,000 | 440,000 |
| Other Non-Current Liabilities | 1,762,000 | 1,626,000 | 1,527,000 | 1,384,000 | 1,243,000 |
| TOTAL | $28,396,000 | $28,176,000 | $23,421,000 | $22,836,000 | $22,713,000 |
| Total Liabilities | $37,614,000 | $39,249,000 | $33,865,000 | $33,746,000 | $32,603,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,307,067 | 1,317,456 | 1,319,658 | 1,331,822 | 1,366,846 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 18,154,000 | 16,654,000 | 14,949,000 | 13,045,000 | 18,001,000 |
| Other shareholders' equity | 754,000 | 384,000 | 533,000 | 457,000 | 667,000 |
| TOTAL | $19,363,000 | $17,360,000 | $16,115,000 | $14,019,000 | $19,113,000 |
| Total Liabilities And Equity | $56,977,000 | $56,609,000 | $49,980,000 | $47,765,000 | $51,716,000 |